The Bermuda Cancer and Health Centre will share 20 years of local cancer data gathered through a comprehensive hereditary cancer programme.

A BCHC spokeswoman said that it would share the results, which involved more than 500 Bermudians, at the Bermuda Principles 30th Anniversary Conference from Wednesday to Saturday.

She added: “Behind each result is a Bermudian family making informed decisions about screening, prevention and the health of the next generation.

“This programme represents Bermuda’s first population-based longitudinal data regarding hereditary cancer risk, not a single moment of testing, but a long-term commitment to walking alongside families over time.”

Since the programme launched in 2006, it evolved from single-gene testing to comprehensive multi-gene panels encompassing more than 90 genes.

It has documented “founder mutations” within Bermuda’s population, with ancestral origins traceable to the United Kingdom, Canada, the United States, the Azores and the Middle East.

Chris Fosker, chief executive, medical director and oncologist at BCHC, said: “Our work in cancer genetics over the past two decades has focused on delivering evidence-based care to our community.

“Presenting this retrospective analysis reflects the centre’s leadership in hereditary cancer management.”